Speaker illustration

Doctor Anna Gvozdeva

National Medical Research Center for Cardiology, Moscow (Russian Federation)

Angiotensin neprilysin inhibition in HFpEF and advanced left ventricular hypertrophy: the rationale, design, and preliminary results of a randomized open-label pilot study

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: ePoster session

Thumbnail